LIN28B and hepatocellular carcinoma: We propose that EpCAM alone may not be sufficient in the identification of HCC stem cells and that Lin28B could be a novel HCC stem cell marker, in addition to CD133, CD90, CD44, OVA6, ALDH, and CD13 [39].